MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression

Cellular Signalling

Volumn 26, Issue 7, 2014, Pages 1420-1426

  Tang, Weiwei ^a   Jiang, Yi ^a   Mu, Xiaoxin ^a   Xu, Lei ^a,b   Cheng, Wenjun ^a   Wang, Xinru ^c,d  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d Nanjing Medical University   (China)

Author keywords

Adhesion; Apoptosis; Epithelial ovarian cancer; HOXA10; MiR 135a

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; MICRORNA; MICRORNA 135A; PLATINUM COMPLEX; PROTEIN BCL 2; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR HOXA10; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; HOMEODOMAIN PROTEIN; HOXA10 PROTEIN, HUMAN; MIRN135 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DOWN REGULATION; DRUG EFFECT; EMBRYO; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; ADOLESCENT; BIOSYNTHESIS; CELL PROLIFERATION; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CASPASE 3; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HOMEODOMAIN PROTEINS; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84897416458     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.03.002     Document Type: Article

References (34)

1. Siegel R., Ma J., Zou Z., Jemal A. CA Cancer J. Clin. Jan. 2014, 64(1):9-29.
2. Bartel D.P. Cell Jan. 23 2004, 116(2):281-297.
3. Poy M.N., Eliasson L., Krutzfeldt J., et al. Nature Nov. 11 2004, 432(7014):226-230.
4. Brennecke J., Hipfner D.R., Stark A., Russell R.B., Cohen S.M. Cell Apr. 4 2003, 113(1):25-36.
5. Xu P., Guo M., Hay B.A. Trends Genet. Dec. 2004, 20(12):617-624.
6. Chen C.Z., Li L., Lodish H.F., Bartel D.P. Science Jan. 2 2004, 303(5654):83-86.
7. Cheng A.M., Byrom M.W., Shelton J., Ford L.P. Nucleic Acids Res. 2005, 33(4):1290-1297.
8. He L., Thomson J.M., Hemann M.T., et al. Nature Jun. 9 2005, 435(7043):828-833.
9. Lu J., Getz G., Miska E.A., et al. Nature Jun. 9 2005, 435(7043):834-838.
10. Pencheva N., Tavazoie S.F. Nat. Cell Biol. Jun. 2013, 15(6):546-554.
11. Esquela-Kerscher A., Slack F.J. Nat. Rev. Cancer Apr. 2006, 6(4):259-269.
12. Kent O.A., Mendell J.T. Oncogene Oct. 9 2006, 25(46):6188-6196.
13. Zhang L., Huang J., Yang N., et al. Proc. Natl. Acad. Sci. U. S. A. Jun. 13 2006, 103(24):9136-9141.
14. Iorio M.V., Visone R., Di L.G., et al. Cancer Res. Sep. 15 2007, 67(18):8699-8707.
15. Vang S., Wu H.T., Fischer A., et al. PLoS One 2013, 8(3):e58226.
16. Zheng H., Zhang L., Zhao Y., et al. PLoS One 2013, 8(11):e77853.
17. Chariot A., Gielen J., Merville M.P., Bours V. Biochem. Pharmacol. Dec. 15 1999, 58(12):1851-1857.
18. Kelly M., Daftary G., Taylor H.S. Am. J. Obstet. Gynecol. Apr. 2006, 194(4):1100-1107.
19. bate-Shen C. Nat. Rev. Cancer Oct. 2002, 2(10):777-785.
20. Cheng W., Liu J., Yoshida H., Rosen D., Naora H. Nat. Med. May 2005, 11(5):531-537.
21. Li B., Jin H., Yu Y., et al. Int. J. Gynecol. Cancer Nov. 2009, 19(8):1347-1352.
22. Chen Y., Zhang J., Wang H., et al. BMC Cancer 2012, 12:111.
23. Liu S., Guo W., Shi J., et al. J. Hepatol. Feb. 2012, 56(2):389-396.
24. Nagel R., le S.C., Diosdado B., et al. Cancer Res. Jul. 15 2008, 68(14):5795-5802.
25. Zhou W., Li X., Liu F., et al. Acta Biochim. Biophys. Sin. (Shanghai) Oct. 2012, 44(10):838-846.
26. Wu H., Huang M., Cao P., Wang T., Shu Y., Liu P. Cancer Biol. Ther. Mar. 2012, 13(5):281-288.
27. Yamada Y., Hidaka H., Seki N., et al. Cancer Sci. Mar. 2013, 104(3):304-312.
28. Navarro A., Diaz T., Martinez A., et al. Blood Oct. 1 2009, 114(14):2945-2951.
29. Wu S., Lin Y., Xu D., et al. Oncogene Aug. 23 2012, 31(34):3866-3874.
30. Hothorn T., Lausen B. Comput. Stat. Data Anal. 2003, 43:121-137.
31. Bromleigh V.C., Freedman L.P. Genes Dev. Oct. 15 2000, 14(20):2581-2586.
32. Chu M.C., Selam F.B., Taylor H.S. Cancer Biol. Ther. Jun. 2004, 3(6):568-572.
33. Haldar S., Negrini M., Monne M., Sabbioni S., Croce C.M. Cancer Res. Apr. 15 1994, 54(8):2095-2097.
34. Miyashita T., Krajewski S., Krajewska M., et al. Oncogene Jun. 1994, 9(6):1799-1805.